The DOI matches its Crossref record; 179 of the 187 references it cites were found in a registry or an index; none of the 14 sources its claims cite is checked for support yet.
Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials
Open accessAbstract
BACKGROUND: Telemedicine, the use of telecommunications to deliver health services, expertise and information, is a promising but unproven tool for improving the quality of diabetes care. We summarized the effectiveness of different methods of telemedicine for the management of diabetes compared with usual care. METHODS: We searched MEDLINE, Embase and the Cochrane Central Register of Controlled Trials databases (to November 2015) and reference lists of existing systematic reviews for randomized controlled trials (RCTs) comparing telemedicine with usual care for adults with diabetes. Two independent reviewers selected the studies and assessed risk of bias in the studies. The primary outcome was glycated hemoglobin (HbA1C) reported at 3 time points (≤ 3 mo, 4–12 mo and > 12 mo). Other outcomes were quality of life, mortality and episodes of hypoglycemia. Trials were pooled using randomeffects meta-analysis, and heterogeneity was quantified using the I2 statistic. RESULTS: From 3688 citations, we identified 111 eligible RCTs (n = 23 648). Telemedicine achieved significant but modest reductions in HbA1C in all 3 follow-up periods (difference in mean at ≤ 3 mo: −0.57%, 95% confidence interval [CI] −0.74% to −0.40% [39 trials]; at 4–12 mo: −0.28%, 95% CI −0.37% to −0.20% [87 trials]; and at > 12 mo: −0.26%, 95% CI −0.46% to −0.06% [5 trials]). Quantified heterogeneity (I2 statistic) was 75%, 69% and 58%, respectively. In meta-regression analyses, the effect of telemedicine on HbA1C appeared greatest in trials with higher HbA1C concentrations at baseline, in trials where providers used Web portals or text messaging to communicate with patients and in trials where telemedicine facilitated medication adjustment. Telemedicine had no convincing effect on quality of life, mortality or hypoglycemia. INTERPRETATION: Compared with usual care, the addition of telemedicine, especially systems that allowed medication adjustments with or without text messaging or a Web portal, improved HbA1C but not other clinically relevant outcomes among patients with diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 10 Not checked · 75 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“| Partially reported | 22 | 0.30 (0.11 to 0.48) | 0.003 |”
§ Effect of telemedicine on > Conclusion
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Choice of patienttoprovider platform (smartphone application, Web portal, smart device, telephone) did not significantly modify the effect of telemedicine on HbA 1C .”
§ Effect of telemedicine on > Meta-regression analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tri als that partially reported loss to followup (i.e., no stated reasons for loss to followup, or loss was reported for the whole trial and not by group) showed a smaller difference in HbA 1C than trials with fully reported loss to followup or trials that did not report loss to followup (difference in MD 0.30%, 95% CI 0.11% to 0.48%).”
§ Effect of telemedicine on > Meta-regression analysis
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no evidence of selective reporting of subscores for quality of life.”
§ Effect of telemedicine on > % of studies
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The metaregression analyses suggested that telemedicine inter ventions that facilitated medication adjustments were more effec tive in improving glycemic control than interventions that did not al low such adjustements.”
§ Effect of telemedicine on > Interpretation
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
24 more claims
Create a free account to see all 85 claims and to verify the 14 references still open.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 44
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The included studies exhibited substantial heterogeneity (I²=94%), a common finding in telemedicine reviews, where heterogeneity typically ranges from 65% to 99% [17,22,86,93].”
From Clinical Improvements From Telemedicine Interventions for Managing Type 2 Diabetes Compared With Usual Care: Systematic Review, Meta-Analysis, and Meta-Regression (2026) · cites this paper as [93]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“3 reviews [28, 31, 43] reported that interventions as simple as text-messaging or SMS feedback were equally effective in improving HbA1c, compared to a teleconference or telephone appointment with healthcare professionals.”
From Effect of virtual care in type 2 diabetes management – a systematic umbrella review of systematic reviews and meta-analysis (2025) · cites this paper as [31]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The included studies exhibited substantial heterogeneity (I²=94%), a common finding in telemedicine reviews, where heterogeneity typically ranges from 65% to 99% [17,22,86,93].”
From Clinical Improvements From Telemedicine Interventions for Managing Type 2 Diabetes Compared With Usual Care: Systematic Review, Meta-Analysis, and Meta-Regression (2026) · cites this paper as [93]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A potential solution to support ongoing diabetes self-management support is the use of telemedicine, 12 which has been suggested as a promising but unproven approach to support people with diabetes in the management of their disease. 13”
From The Effectiveness of Telemedicine Solutions for the Management of Type 2 Diabetes: A Systematic Review, Meta-Analysis, and Meta-Regression (2023) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with previous findings [87,93], the majority of the evidence (72%) originates from high-income countries, with the United States contributing the highest proportion (28%).”
From Clinical Improvements From Telemedicine Interventions for Managing Type 2 Diabetes Compared With Usual Care: Systematic Review, Meta-Analysis, and Meta-Regression (2026) · cites this paper as [93]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Effect of telemedicine on > Meta-regression analysis
“Both trial region and baseline HbA 1C modified the effect of telemedicine on final HbA 1C”
§ Effect of telemedicine on > Limitations
“Baseline HbA 1C (range 6.4%-10.7%)87 -0.06 per 1% (-0.16 to 0.04) 0.3 68”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Effect of telemedicine on > Limitations
“Duration of followup (range 2.6-24 yr) 52 0.008 per 1 yr (-0.02 to 0.03) 0.5 69”
§ Effect of telemedicine on > Effect on HbA 1C
“Thirtynine trials (n = 3165) reported the effect of telemedicine on HbA 1C at 3 months or less”
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Research works printed but not linked: 22
- [3]3. The Diabetes Control and Complications Trial Research Group. The effect of inten sive treatment of diabetes on the development and progression of longterm com plications in insulindependent diabetes mellitus. N Engl J Med 1993;329:97786.
- [12]12. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002;288:17759.
- [17]17. Liang X, Wang Q, Yang X, et al. Effect of mobile phone intervention for diabetes on glycaemic control: a metaanalysis. Diabet Med 2011;28:45563.
- [40]40. Bassler D, Briel M, Montori VM, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and metaregression analy sis. JAMA 2010;303:11807.
- [41]41. DerSimonian R, Laird N. Metaanalysis in clinical trials. Control Clin Trials 1986;7:17788.
- [44]44. Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a sim ple, graphical test. BMJ 1997;315:62934.
- [45]45. Peters JL, Sutton AJ, Jones DR, et al. Contourenhanced metaanalysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 2008;61:9916.
- [46]46. Thompson SG, Higgins JP. How should metaregression analyses be under taken and interpreted? Stat Med 2002;21:155973.
- [52]52. Bell AM, Fonda SJ, Walker MS, et al. Mobile phonebased video messages for diabetes selfcare support. J Diabetes Sci Technol 2012;6:3109.
- [58]58. Carter EL, NunleeBland G, Callender C. A patientcentric, provider assisted dia betes telehealth selfmanagement intervention for urban minorities. Perspect Health Inf Manag 2011;8:1b.
- [61]61. Cho JH, Chang SA, Kwon HS, et al. Longterm effect of the Internetbased glu cose monitoring system on HbA1c reduction and glucose stability: a 30month followup study for diabetes management with a ubiquitous medical care sys tem. Diabetes Care 2006;29:262531.
- [64]64. Dale J, Caramlau I, Sturt J, et al. Telephone peerdelivered intervention for dia betes motivation and support: the telecare exploratory RCT. Patient Educ Couns 2009;75:918.
- [75]75. Glasgow RE, Kurz D, King D, et al. Twelvemonth outcomes of an Internetbased diabetes selfmanagement support program. Patient Educ Couns 2012;87:8192.
- [99]99. Kirwan M, Vandelanotte C, Fenning A, et al. Diabetes selfmanagement smart phone application for adults with type 1 diabetes: randomized controlled trial. J Med Internet Res 2013;15:e235.
- [103]103. Lorig K, Ritter PL, Laurent DD, et al. Online diabetes selfmanagement program: a randomized study. Diabetes Care 2010; 33: 127581.
- [109]109. McMahon GT, Gomes HE, Hickson Hohne S, et al. Webbased care manage ment in patients with poorly controlled diabetes. Diabetes Care 2005;28: 16249.
- [118]118. Pacaud D, Kelley H, Downey AM, et al. Successful delivery of diabetes selfcare education and followup through ehealth media. Can J Diabetes 2012;36: 25762.
- [126]126. Ralston JD, Hirsch IB, Hoath J, et al. Webbased collaborative care for type 2 diabetes: a pilot randomized trial. Diabetes Care 2009;32:2349.
- [142]142. Tsang MW, Mok M, Kam G, et al. Improvement in diabetes control with a moni toring system based on a handheld, touchscreen electronic diary. J Telemed Telecare 2001;7:4750.
- [148]148. Weinberger M, Kirkman MS, Samsa GP, et al. A nursecoordinated intervention for primary care patients with noninsulindependent diabetes mellitus: impact on gly cemic control and healthrelated quality of life. J Gen Intern Med 1995;10:5966.
- [149]149. Whitlock WL, Brown A, Moore K, et al. Telemedicine improved diabetic manage ment. Mil Med 2000;165:57984.
- [163]163. Handley MA, Shumway M, Schillinger D. Costeffectiveness of automated tele phone selfmanagement support with nurse care management among patients with diabetes. Ann Fam Med 2008;6:5128.
Cited by
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
Greenwood, D. A., Gee, P. M., Fatkin, K. J., & Peeples, M. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817713506 · Cited by 526
The clinical effectiveness of telehealth: A systematic review of meta-analyses from 2010 to 2019
Snoswell, C. L., Chelberg, G., De Guzman, K. R., Haydon, H. M., Thomas, E. E., Caffery, L. J., & Smith, A. C. (2023) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x211022907 · Cited by 397
Improving Access to Care: Telemedicine Across Medical Domains
Barbosa, W., Zhou, K., Waddell, E., Myers, T., & Dorsey, E. R. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090519-093711 · Cited by 299
Metadata
- Authors
- Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., Manns, B. J., & Tonelli, M.
- Affiliations
- University of Alberta (CA)
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Impact Inc.
- Published
- 2016-10-31
- Volume
- 189
- Issue
- 9
- Pages
- E341-E364
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- PMC
- PMC5334006
- OpenAlex
- W2546067499
- Cited by
- 281
- References
- 187
- Citations by year
- 2026: 14 · 2025: 25 · 2024: 33 · 2023: 29 · 2022: 46 · 2021: 46 · 2020: 32 · 2019: 25 · 2018: 18 · 2017: 12 · 2016: 1
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Canadian Medical Association Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- telemedicine, diabetes mellitus, HbA1c, glycemic control, diabetes management, web portal, text messaging, medication adjustment, quality of life, hypoglycemia, mortality
- MeSH terms
- Communication, Diabetes Mellitus, Glycated Hemoglobin, Humans, Hypoglycemia, Quality of Life, Randomized Controlled Trials as Topic, Telemedicine, Disease Management, Internet, Text Messaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. https://app.cochat.ai/papers/10.1503/cmaj.150885
- The paper
- Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., Manns, B. J., & Tonelli, M. (2017). Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.150885
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.